Author(s)

Fernanda Aparecida De Oliveira Peixoto¹, Célia Regina Malveste Ito^2*, André Luís Elias Moreira², Paulo Alex N. Silva², Mônica Oliveira Santos², Isabela Jubé Wastowski³, Liana De Medeiros Machado Braga⁴, Vivian Da Cunha Rabelo⁴, Lilian Carla Carneiro², Melissa Ameloti Gomes Avelino^1,5

¹Department of Pediatrics, Neonatal ICU of Clinical Hospital of Federal University of Goiás/Ebserh, Goiania, Brazil.
²Microorganism Biotechnology Laboratory of Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiania, Brazil.
³Molecular Immunology Laboratory of Goiás State University, Anápolis, Brazil.
⁴Pediatrics ICU of State Emergency Hospital Governor Otávio Lage of Siqueira, Goiania, Brazil.
⁵Surgical Department of Pediatrics, Medical School, Federal University of Goiás, Goiania, Brazil.

Pediatric Multisystemic Inflammatory Syndrome (MIS-C) is one of the most severe manifestations of SARS-CoV-2 in pediatrics [1]. This is a report of MIS-C with clinical presentation in infants with atypical Hemolytic Uremic Syndrome (aHUS).

MISC, COVID-19, aHUS, Children, Critical Care

Peixoto, F. , Ito, C. , Moreira, A. , Silva, P. , Santos, M. , Wastowski, I. , Braga, L. , Rabelo, V. , Carneiro, L. and Avelino, M. (2022) Atypical Hemolytic Uremic Syndrome in a Post-COVID-19 Child: Its Differential Diagnosis with COVID-19, Multisystemic Inflammatory Syndrome and Outcome. Open Journal of Pediatrics, 12, 657-664. doi: 10.4236/ojped.2022.124067.